Characteristic | No of patients | % of patients |
Patients enrolled | 143 | |
Age (y) | ||
Median | 64 | |
Range | 25–83 | |
Sex | ||
Male | 114 | 80 |
Female | 29 | 20 |
Symptomatic patients | 85 | 59 |
Present and past smokers | 121 | 85 |
CEA level (ng/ml) | ||
Median | 6.2 | |
Range | 0.7–347.7 | |
Tumour location | ||
RUL/RML/RLL | 32/8/46 | 22/6/32 |
LUL/LLL | 34/23 | 24/16 |
Clinical T status | ||
T1/T2/T3/T4 | 20/88/27/8 | 14/61/19/6 |
Resection type | ||
Pneumonectomy | 42 | 29 |
Bilobectomy | 35 | 25 |
Lobectomy | 66 | 46 |
Histological type | ||
Squamous cell carcinoma | 69 | 48 |
Adenocarcinoma | 54 | 38 |
Large cell carcinoma | 10 | 7 |
Adenosquamous carcinoma | 6 | 4 |
Other* | 4 | 3 |
*Two atypical carcinoids, one pleomorphic carcinoma and one giant cell carcinoma.
CEA, carcinoembryonic antigen; LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe.